New DNA And RNA Aptamers Offer Unique Therapeutic Advantages
Monday, August 10, 2009 - 02:35
in Biology & Nature
A novel class of drugs composed of single strands of DNA or RNA, called aptamers, can bind protein targets with a high strength and specificity and are currently in clinical development as treatments for a broad range of common diseases, as described in a comprehensive review.